Distinct [18F]FDG-PET imaging features of a newly recognized and yet uncharacterized RDD-ECD overlap disease entity Martin W. HuellnerMarco M. BühlerWiebke Rösler Image of the Month Open access 17 May 2024
Assessment of cerebral drug occupancy in humans using a single PET-scan: A [11C]UCB-J PET study Maja R. Marstrand-JoergensenGjertrud L. LaurellLars H. Pinborg Original Article Open access 17 May 2024
FAPI PET uptake patterns after invasive medical interventions: a single center retrospective analysis Peter George MalihaMasatoshi HottaJeremie Calais Original Article 16 May 2024
Comment on: Is work overload associated with diagnostic errors on [18F]FDG PET/CT Guillaume HourcauDavid Taïeb Letter to the Editor 14 May 2024
Cholecystokinin-2 receptor targeting by [68Ga]Ga-DOTA-MGS5 PET/CT in a patient with extensive disease small cell lung cancer Gianpaolo Di SantoGiulia SantoIrene Virgolini Image of the Month Open access 14 May 2024
Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer Sofia C. VazJohn Patrick Pilkington WollLioe-Fee de Geus-Oei Guidelines Open access 14 May 2024
The EANM-SNMMI guideline on the role of [18F]FDG-PET/CT in breast cancer: Important milestones and perspectives for the future Elif Hindié Editorial 13 May 2024
Biological characterization of renal masses using immuno-PET Fabrizia GelardiAlessandro LarcherArturo Chiti Editorial 11 May 2024 Pages: 2442 - 2443
CYP3A4 inhibitors may influence the quantification of [123I]I-FP-CIT SPECT scans Jan BooijEda YağciYoussef Chahid Short Communication Open access 11 May 2024
Seasonal variation in D2/3 dopamine receptor availability in the human brain Lihua SunTuulia MalénLauri Nummenmaa Original Article Open access 11 May 2024
Radiolabelling and preclinical characterisation of [89Zr]Zr-Df-ATG-101 bispecific to PD-L1/4–1BB Zhipeng CaoChristian Werner WichmannAndrew Mark Scott Original Article Open access 11 May 2024
Coronary sodium [18F]fluoride activity predicts outcomes post-CABG: a comparative evaluation with conventional metrics Mingxin GaoWanwan WenXiang Li Original Article 11 May 2024
Diagnostic efficacy of [68Ga]Ga-DOTA-GPFAPI-04 in patients with solid tumors in a head-to-head comparison with [18F]F-FDG: results from a prospective clinical study Hui YuanEntao LiuLei Jiang Original Article 10 May 2024
A head-to-head comparison of [68Ga]Ga-DOTATATE and [68Ga]Ga-FAPI PET/CT in patients with nasopharyngeal carcinoma: a single-center, prospective study Jieling ZhengGuochang WangWeibing Miao Original Article 10 May 2024
The impact of PET/CT and brain MRI for metastasis detection among patients with clinical T1-category lung cancer: Findings from a large-scale cohort study Yi FengBo ChengWenhua Liang Original Article Open access 09 May 2024
Imaging CAR-NK cells targeted to HER2 ovarian cancer with human sodium-iodide symporter-based positron emission tomography Nourhan ShalabyYing XiaJohn A. Ronald Original Article Open access 09 May 2024
Total-body imaging of mu-opioid receptors with [11C]carfentanil in non-human primates Chia-Ju HsiehCatherine HouRobert H. Mach Original Article Open access 09 May 2024
Pre-therapy PET-based voxel-wise dosimetry prediction by characterizing intra-organ heterogeneity in PSMA-directed radiopharmaceutical theranostics Song XueAndrei GafitaKuangyu Shi Original Article Open access 09 May 2024
Efficiency of succinylated gelatin and amino acid infusions for kidney uptake reduction of radiolabeled αvβ6-integrin targeting peptides: considerations on clinical safety profiles Stefan StanglNghia Trong NguyenJohannes Notni Original Article Open access 08 May 2024
Assessment of [18F]PI-2620 Tau-PET Quantification via Non-Invasive Automatized Image Derived Input Function Maria MeindlArtem ZatcepinMatthias Brendel Original Article Open access 08 May 2024
Collection on molecular imaging in cardiac amyloidosis Federico CaobelliChristoph Rischpler Editorial 07 May 2024 Pages: 2163 - 2164
[18F]AlF-NOTA-PCP2: a novel PET/CT tracer for enhanced PD-L1 heterogeneity imaging and comparative analysis with [18F]AlF-NOTA-WL12 in glioblastoma xenografts Yong WangYang ZhangMan Hu Original Article 07 May 2024
Joint EANM-SNMMI guidelines on the role of 2-[18F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines David GroheuxSofia C. VazLioe-Fee de Geus-Oei Editorial 02 May 2024
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours Paola MapelliCarolina BezziMaria Picchio Original Article 02 May 2024
Comparison of discovery rates and prognostic utility of [68Ga]Ga-PSMA-11 PET/CT and circulating tumor DNA in prostate cancer—a cross-sectional study Kilian KlugeHolger EinspielerAlexander Haug Original Article Open access 02 May 2024
Multicenter PET image harmonization using generative adversarial networks David HaberlClemens P. SpielvogelLaszlo Papp Original Article Open access 02 May 2024
Development and validation of [18 F]-PSMA-1007 PET-based radiomics model to predict biochemical recurrence-free survival following radical prostatectomy Tiancheng LiMimi XuXinhui Su Original Article 01 May 2024
EANM position on positron emission tomography in suspected functional pituitary neuroendocrine tumours Donatienne Van WeehaegheBruno LapauwElsmarieke Van De Giessen Editorial 30 April 2024 Pages: 2367 - 2370
[68Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation Miriam PepponiValentina BertiAlessio Imperiale Original Article 30 April 2024
Nuclear medicine practice for the assessment of cardiac sarcoidosis and amyloidosis. A survey endorsed by the EANM and EACVI. Irene GotuzzoRiemer H.J.A. SlartPaola A. Erba Editorial 29 April 2024 Pages: 1809 - 1815
Development and first-in-human study of PSMA-targeted PET tracers with improved pharmacokinetic properties Haodong HouYuan PanFeng Gao Original Article 29 April 2024
Can current preclinical strategies for radiopharmaceutical development meet the needs of targeted alpha therapy? Janke KleynhansThomas EbenhanMike Machaba Sathekge Review Article Open access 27 April 2024 Pages: 1965 - 1980
Validation of cardiac image-derived input functions for functional PET quantification Murray Bruce ReedPatricia Anna HandschuhAndreas Hahn Original Article Open access 27 April 2024
EANM consensus document on the use of [18F]FDG PET/CT in fever and inflammation of unknown origin Søren HessEdel Noriega-ÁlvarezOlivier Gheysens Original Article Open access 27 April 2024
Correction to: Highlights of the 36th EANM Annual Congress 2023, from hometown Vienna, Austria: “A SYMPHONY OF SCIENCE” David KerstingSilvia MorbelliHein J. Verberne Correction Open access 25 April 2024 Pages: 2159 - 2159
Comparison of novel PSMA-targeting [177Lu]Lu-P17-087 with its albumin binding derivative [177Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study Linlin LiJiarou WangZhaohui Zhu Original Article 25 April 2024
Letter to the editor concerning “Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?” An-Li YuCheng-Hsuan TsaiYen-Hung Lin Letter to the Editor 24 April 2024 Pages: 2161 - 2162
How nuclear imaging changed parathyroid surgical strategies through time H. M. SchouwM. E. NoltesS. Kruijff Editorial 23 April 2024 Pages: 2165 - 2171
Enhancing surgical outcomes: accurate identification and removal of prostate cancer with B7-H3-targeted NIR-II molecular imaging Yaqi TianHongliang ShenJie Tian Original Article 22 April 2024
Synthesis and preclinical evaluation of novel 18F-vancomycin-based tracers for the detection of bacterial infections using positron emission tomography G. B. SpoelstraS. N. BlokP. H. Elsinga Original Article Open access 22 April 2024
Combined, yet separate: cocktails of carriers (not drugs) for actinium-225 α-particle therapy of solid tumors expressing moderate-to-low levels of targetable markers Rajiv Ranjit NairAprameya PrasadStavroula Sofou Original Article 20 April 2024
The role of [18 F]FDOPA PET as an adjunct to conventional MRI in the diagnosis of aggressive glial lesions Adeline ZinszCelso PougetAntoine Verger Original Article 19 April 2024
B-Glycine as a marker for β cell imaging and β cell mass evaluation Yuxiang HanHui LiuZhibo Liu Original Article 18 April 2024
Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer Hong SongMaria Isabel LeonioAndrei Iagaru Original Article 18 April 2024
Cadherin-17 as a target for the immunoPET of adenocarcinoma Samantha DelaneyOuti KeinänenBrian M. Zeglis Original Article Open access 16 April 2024
Intraoperative image-guidance during robotic surgery: is there clinical evidence of enhanced patient outcomes? Stefano TapperoGiuseppe FallaraPaolo Dell’Oglio Review Article 12 April 2024
Visual extended reality tools in image-guided surgery in urology: a systematic review Enrico CheccucciAlberto PianaFrancesco Porpiglia Review Article 09 April 2024
Artificial intelligence-based application in multiple myeloma Leandra PiscopoMariano ScaglioneMichele Klain Editorial 08 April 2024 Pages: 1923 - 1925
PET/CT study of dopamine transporter (DAT) binding with the triple reuptake inhibitor toludesvenlafaxine in rats and humans Zhiwei HuangJunhao WuYifeng Shen Original Article 08 April 2024
Clinicopathological and molecular predictors of [18F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial Antonio Llombart-CussacAleix PratGeraldine Gebhart Original Article Open access 08 April 2024